Healthcare Services

Expanded Carrier Screening Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Expanded Carrier Screening Market Across 2026–2030?

The expanded carrier screening market has experienced swift expansion recently. This market is projected to expand from $2.46 billion in 2025 to $2.87 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 16.7%. Historically, this growth has been driven by several factors, including heightened awareness of inherited genetic disorders, the broadening of prenatal screening initiatives, advancements in genetic sequencing accuracy, the increasing presence of diagnostic laboratories, and the growing uptake of carrier screening tools by clinicians.

The expanded carrier screening market size is projected to experience substantial growth over the upcoming years. It is forecast to expand to $5.28 billion by 2030, achieving a compound annual growth rate (CAGR) of 16.4%. This anticipated growth during the forecast period is fueled by an escalating demand for tailored reproductive health solutions, the increasing incorporation of AI-based variant interpretation, the broadening of population-wide screening programs, expanding investments in genomic data platforms, and a heightened emphasis on preventive genetic healthcare. Significant trends anticipated in the forecast period involve a greater adoption of pan-ethnic genetic screening panels, a rising need for preconception carrier testing, the growing application of next-generation sequencing technologies, the proliferation of direct-to-provider genetic testing services, and an enhanced focus on integrating genetic counseling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28215&type=smp

What Drivers Are Shaping The Future Growth Of The Expanded Carrier Screening Market?

An increase in the occurrence of genetic diseases is anticipated to boost the expansion of the expanded carrier screening market in the future. These are conditions resulting from irregularities or alterations in a person’s DNA, which can be passed down or emerge without prior family history. The frequency of genetic diseases is on the rise due to progress in diagnostic methods, such as next-generation sequencing and various genomic instruments, which have substantially enhanced the capacity to discover and pinpoint numerous genetic disorders that were previously undetected or incorrectly categorized. Expanded carrier screening plays a crucial role in identifying individuals who carry genetic disorders prior to symptom manifestation, facilitating informed choices about reproduction and lessening the likelihood of transmitting inherited conditions to subsequent generations. For example, as reported in October 2024 by the Cystic Fibrosis Trust, a UK charity assisting individuals with cystic fibrosis, the year 2022 saw 11,148 registered cystic fibrosis patients, a figure which climbed to 11,318 in 2023, indicating a 1.5% year-over-year rise in patient registrations. Consequently, the growing incidence of genetic diseases is propelling the expansion of the carrier screening market.

What Segmentation Levels Are Considered In The Expanded Carrier Screening Market?

The expanded carrier screening market covered in this report is segmented –

1) By Type: Customized Panel Testing, Predesigned Panel Testing

2) By Technology: Deoxyribonucleic Acid Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

3) By Application: Preconception, Prenatal, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Laboratories, Specialty Clinics, Other End-Users

Subsegments:

1) By Customized Panel Testing: Single Gene Testing, Multi-Gene Panel Testing, Ethnicity-Based Custom Panels, Condition-Specific Custom Panels, Family History-Based Custom Panels

2) By Predesigned Panel Testing: Pan-Ethnic Panels, Universal Carrier Panels, Population-Specific Panels, Disorder-Focused Panels, Expanded Predefined Panels

What Key Developments And Trends Are Impacting The Expanded Carrier Screening Market?

Leading companies in the expanded carrier screening market are focusing on developing innovative solutions, such as comprehensive next-generation sequencing-based panels, to detect a broad spectrum of genetic conditions with improved accuracy and efficiency. These comprehensive next-generation sequencing (NGS)-based panels are advanced genetic tests that analyze multiple genes simultaneously to identify a wide range of inherited disorders with high accuracy and speed. For instance, in February 2023, Fulgent Genetics Inc., a US-based genomic testing company, launched the Beacon787 Expanded Carrier Screening Panel, designed to evaluate 787 genes linked to severe inherited conditions. This panel offers extensive coverage of over 700 autosomal recessive and X-linked disorders, including all Tier 3 genes. It leverages advanced next-generation sequencing technology that provides high analytical accuracy, a pan-ethnic approach, and a quick turnaround time of 2–3 weeks, positioning it as one of the most comprehensive and precise reproductive carrier screening solutions available.

Which Leading Firms Are Contributing To The Growth Of The Expanded Carrier Screening Market?

Major companies operating in the expanded carrier screening market are Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BGI Genomics Co. Ltd., Ambry Genetics Corporation, GeneDx Inc., BillionToOne Inc., MedGenome Labs Ltd., Centogene N.V., Baylor Miraca Genetics Laboratories LLC, Victorian Clinical Genetics Services, Pathkind Diagnostics Private Limited, Medicover Genetics GmbH, NxGen MDx LLC, GeneTech

Read the full expanded carrier screening market report here:

https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

Which Geographic Regions Are Influencing Demand In The Expanded Carrier Screening Market?

North America was the largest region in the expanded carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the expanded carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Expanded Carrier Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28215&type=smp

Browse Through More Reports Similar to the Global Expanded Carrier Screening Market 2026, By The Business Research Company

Security Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

Wireless Telecommunication Carrier Global Market Report

https://www.thebusinessresearchcompany.com/report/wireless-telecommunication-carrier-global-market-report

Cellular Health Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795